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c
 
ntegrin-mediated cell adhesion to extracellular matrix
proteins is known to promote cell survival, whereas de-
tachment from the matrix can cause rapid apoptotic
death in some cell types. Contrary to this paradigm, we
show that ﬁbroblast adhesion to the angiogenic matrix
protein CCN1 (CYR61) induces apoptosis, whereas en-
dothelial cell adhesion to CCN1 promotes cell survival.
CCN1 induces ﬁbroblast apoptosis through its adhesion
receptors, integrin 
 
 
 
6
 
 
 
1
 
 and the heparan sulfate pro-
I
 
teoglycan (HSPG) syndecan-4, triggering the transcrip-
tion-independent p53 activation of Bax to render cyto-
chrome 
 
c
 
 release and activation of caspase-9 and -3.
Neither caspase-8 activity nor de novo transcription or
translation is required for this process. These results show
that cellular interaction with a speciﬁc matrix protein can
either induce or suppress apoptosis in a cell type–speciﬁc
manner and that integrin 
 
 
 
6
 
 
 
1
 
-HSPGs can function as
receptors to induce p53-dependent apoptosis.
 
Introduction
 
Cellular interaction with the ECM, occurring largely through
integrin receptors, is a principal regulator of cell survival.
Several abundant ECM proteins are known to induce potent
prosurvival signals in specific cell types, although others are
neutral to cell survival (Ilic et al., 1998). Many types of normal
cells are anchorage dependent; when detached from the ECM
these cells undergo anoikis, a form of apoptotic death (Frisch
and Screaton, 2001; Grossmann, 2002). This apoptotic mecha-
nism plays a critical role in controlling homeostasis and the in-
tegrity of tissue architecture. Malignant tumor cells are often
resistant to anoikis, thus promoting metastasis by allowing
these cells to migrate through and proliferate in inappropriate
environments (Igney and Krammer, 2002). During embryogen-
esis and tissue remodeling, however, many normal cells un-
dergo programmed cell death under the control of apoptotic
factors without detachment from the ECM (Rich et al., 1999;
Baehrecke, 2002). In these instances, dynamic changes in the
matrix environment may provide conditions that are permissive
of, or conducive to, apoptotic processes. However, no specific
ECM protein has been shown to directly trigger cell death
through its cell-adhesive function to date.
The principal receptors for ECM molecules are integrins,
which connect the ECM to the cytoskeleton and transduce
signals induced by their extracellular ligands (Hynes, 2002;
Miranti and Brugge, 2002). Engagement of several specific in-
tegrins has been shown to activate strong prosurvival signaling
pathways; among these pathways FAK plays a critical role (Ilic
et al., 1998; Parsons, 2003). In addition to FAK, some integrins
also recruit Shc and integrin-linked kinase, and these three
signaling molecules mediate ECM-dependent survival signals
through activation of the phosphatidylinositol 3-kinase/Akt,
c-Jun NH
 
2
 
-terminal kinase (JNK), and Erk pathways (Almeida
et al., 2000; Frisch and Screaton, 2001). Detachment of cells
from the ECM blocks these prosurvival pathways and induces
cytoskeletal changes, resulting in the release and activation of
proapoptotic molecules. Whereas cell death by anoikis is often
associated with the activation of caspase-8 or p53 (Frisch and
Screaton, 2001; Grossmann, 2002), unligated 
 
 
 
v
 
 
 
3
 
 or 
 
 
 
1
 
 inte-
grins, even in adherent cells, can also induce apoptosis by the
direct recruitment and activation of caspase-8 (Stupack et al.,
2001). In addition, unligated integrin 
 
 
 
5
 
 
 
1
 
 can trigger the re-
lease of the mitochondrial protein Bit1 into the cytoplasm,
thereby activating a caspase-independent mechanism of cell
death (Jan et al., 2004). Thus, integrin-mediated cell adhesion
events play critical roles in the control of apoptosis.
CCN1 (CYR61) is a secreted matrix-associated heparin-
binding protein that contains structural domains common to
ECM proteins, including the von Willebrand factor type C re-
peat, the thrombospondin type 1 repeat, and the COOH termi-
nus of muscins (Lau and Lam, 1999). Encoded by a growth
factor–inducible immediate early gene, CCN1 regulates a
broad spectrum of cellular activities, including cell adhesion,
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migration, proliferation, survival, and differentiation. Mecha-
nistically, CCN1 acts through direct binding to at least five
distinct integrins, which mediate CCN1 functions in a cell
type– and context-dependent manner (Lau and Lam, 2005).
For example, CCN1 promotes proangiogenic activities in
activated endothelial cells through integrin 
 
 
 
v
 
 
 
3
 
 (Leu et al.,
2002) and supports fibroblast and smooth muscle cell adhe-
sion through integrin 
 
 
 
6
 
 
 
1
 
 with heparan sulfate proteoglycans
(HSPGs) as coreceptors (Chen et al., 2000; Grzeszkiewicz et
al., 2002). Adhesion of primary human fibroblasts to immobi-
lized CCN1 induces adhesive signaling, including the formation
of filopodia and lamellipodia and activation of FAK, paxillin,
Rac, and Erk1/2, culminating in the regulation of genes that
control angiogenesis, inflammation, and matrix remodeling
(Chen et al., 2001a,b). Consistent with these activities, 
 
Ccn1
 
expression in adulthood is associated with biological and
pathological contexts in which angiogenesis and inflammation
play important roles, such as wound healing, restenosis, athero-
sclerosis, and tumorigenesis (Grzeszkiewicz et al., 2002; for re-
view see Menendez et al., 2003). Furthermore, CCN1 induces
angiogenesis both in vitro and in vivo and is essential for suc-
cessful vascular development, as evidenced by the embryonic
lethality of 
 
Ccn1
 
-null mice resulting from placental vascular
insufficiency and loss of embryonic vessel integrity (Babic et
al., 1998; Mo et al., 2002).
CCN1 protects activated endothelial cells from apoptosis
by ligation to integrin 
 
 
 
v
 
 
 
3
 
 and promotes survival in MCF7
breast cancer cells by up-regulation of X-linked inhibitor of
apoptosis (Leu et al., 2002; Lin et al., 2004). However, 
 
Ccn1
 
 ex-
pression has been associated with cell death in the hippocampal
progenitor cell line H19 and in endometrial cancer cells (Kim et
al., 2003; Chien et al., 2004), suggesting that CCN1 may regu-
late cell survival differently in distinct cell types. We show that
CCN1 can promote the survival of activated endothelial cells
but induces apoptosis in fibroblasts. Paradoxically, CCN1 in-
duces fibroblast apoptosis as an adhesion substrate through its
adhesion receptors, integrin 
 
 
 
6
 
 
 
1
 
 and the HSPG syndecan-4, de-
spite activation of the prosurvival protein FAK. Ligation of
CCN1 to the adhesion receptors in fibroblasts, neither of which
has previously been implicated in apoptosis, results in the tran-
scription-independent p53 activation of Bax and cytochrome 
 
c
 
release, triggering the activation of caspase-9 and -3. These
results show that cell adhesion to a specific matrix protein can
either induce or suppress apoptosis in a cell type–dependent
manner and that integrin 
 
 
 
6
 
 
 
1
 
 and syndecan-4 can function as
apoptotic receptors to induce p53-dependent cell death.
 
Results
 
CCN1 induces apoptosis in fibroblasts 
as a cell adhesion substrate
 
To investigate whether CCN1 regulates cell survival in fibro-
blasts, Rat1a cells were adhered to surfaces coated with CCN1
or other ECM proteins and maintained in low serum for 24 h.
Cells were subjected to the TUNEL assay to monitor apoptosis
and counterstained with DAPI, which also marks apoptotic
cells by their intensely staining condensed nuclei (Kennedy et
al., 1997). As expected, cells adherent to fibronectin (FN),
laminin (LN), or vitronectin (VN) were not apoptotic, even un-
der serum deprivation (Fig. 1, A and B). Surprisingly, 
 
 
 
30%
of the cells adhered to CCN1 suffered apoptotic death. By con-
trast, cells did not succumb when attached to poly-
 
L
 
-lysine
(PLL), indicating that a lack of ECM-dependent signals, per se,
was not sufficient to induce apoptosis under these experimental
conditions. Rather, CCN1 was actively inducing apoptosis.
TUNEL-positive cells matched those with intense DAPI
staining precisely, indicating that the same cells were scored
as apoptotic using either assay. FACS analysis showed that
the fraction of cells with sub-G1 DNA content increased from
9.5 to 31.4% after CCN1 treatment, further demonstrating that
CCN1 triggered DNA degradation, a hallmark of apoptosis
(unpublished data).
CCN1 is known to protect activated endothelial cells
from apoptosis (Leu et al., 2002), prompting us to compare its
effects on different cell types. Because CCN1 also functions as
a soluble protein (Babic et al., 1998), we assessed its activities
as an immobilized adhesion substrate and as a soluble factor.
Activated human umbilical vein endothelial cells (HUVECs),
primary normal human skin fibroblasts (HSFs), and Rat1a cells
were adhered to dishes coated with either CCN1 or LN and
subjected to serum deprivation (Fig. 1 C). Alternatively, cells
were adhered on tissue culture dishes overnight and allowed to
secrete their own matrix before the addition of soluble CCN1.
HUVECs were protected from apoptosis upon serum with-
drawal in the presence of CCN1 but not LN, either as adhesion
substrates or as soluble factors. By contrast, CCN1 induces
apoptosis in primary HSFs and Rat1a cells, both as an adhesion
substrate and in a soluble form. The induction of cell death in
primary fibroblasts is remarkable because these cells are rela-
tively resistant to apoptosis induced by many conditions, in-
cluding serum withdrawal. Because the p21-deficient Rat1a
fibroblasts are more prone to cell death (Kennedy et al., 1997)
and showed an enhanced response to CCN1, we have used
Rat1a fibroblasts for most of our subsequent experiments.
However, key observations have been confirmed in primary
HSFs as well (see Fig. 4 B and Fig. 6 D).
Acting as adhesion substrates, various ECM molecules
display cell type–specific effects on cell survival. Cell adhesion
to FN, a ligand of integrin 
 
 
 
5
 
 
 
1
 
, is known to induce potent pro-
survival signals in endothelial cells and fibroblasts, whereas
adhesion to other proteins such as collagen or LN appears neu-
tral to cell survival in fibroblasts (Ilic et al., 1998). Thus, we
tested the activity of CCN1 in cells adhered to specific ECM
molecules. Fibroblasts adherent to FN, VN, or LN were sus-
ceptible to CCN1 cytotoxicity (Fig. 1 D), indicating that the ap-
optotic activity of CCN1 can override any prosurvival signals
resulting from cell adhesion to these ECM proteins.
Fibroblast adhesion to CCN1 is mediated through inte-
grin 
 
 
 
6
 
 
 
1
 
-HSPGs, resulting in 
 
 
 
6
 
 
 
1
 
-containing focal adhesion
complexes and the activation of FAK, paxillin, Rac, and
Erk1/2 (Chen et al., 2001a). Like primary HSFs, Rat1a cells
also adhere to and spread on CCN1, leading to adhesive signal-
ing including tyrosyl phosphorylation of FAK (Fig. 1, A and E).
Specifically, FAK was phosphorylated at Y397, a site known 
CCN1 INDUCES FIBROBLAST APOPTOSIS • TODOROVI  ET AL. C ´
 
561
 
to be autophosphorylated upon integrin signaling and that
serves as a docking site for phosphatidylinositol 3-kinase, as
well as at Y576 and Y577, which are sites that enhance FAK
kinase activity when phosphorylated (Parsons, 2003). Further-
more, similar to cells adhered to FN, virtually 100% of cells
adhered to CCN1 had phosphorylated FAK, leading to the
phosphorylation of paxillin at Y118, a specific substrate of
FAK (Schaller and Parsons, 1995; Fig. 1 F). FAK can also acti-
vate JNK, and phosphorylated JNK is localized in focal adhe-
sions of fibroblasts cultured on prosurvival matrix (Almeida et
al., 2000). We found that fibroblasts adhered to both FN and
CCN1 showed the same pattern of rapid and transient phos-
phorylation of JNK, peaking between 5 and 15 min after adhe-
sion (unpublished data). In fibroblasts adhered to both FN and
CCN1, phosphorylated JNK was localized to the focal com-
plexes (Fig. 1 G). These results show that Rat1a cell adhesion
to CCN1 induces signaling through FAK, even though apopto-
sis ensues under these conditions. Thus, the phosphorylation of
FAK, either by FN or CCN1, is not sufficient to circumvent
CCN1-induced apoptosis.
Induction of apoptosis by CCN1 is dose dependent, ob-
servable at 1.0 
 
 
 
g/ml (25 nM) CCN1, and maximal at 20 
 
 
 
g/ml
when 
 
 
 
90% of cells were apoptotic (Fig. 2 A). This active
concentration range is consistent with that of other integrin-
mediated CCN1 activities (Lau and Lam, 2005). Neither cyclo-
heximide nor 5,6-dichloro-1-
 
 
 
-
 
D
 
-ribofuranosylbenzimidazole
(DRB) was able to block CCN1-induced apoptosis, indicating
that this process does not require de novo translation or tran-
scription (Fig. 2 B). The inclusion of 2% serum in the culture
medium, which is sufficient to sustain cell proliferation for Rat1a
cells (Conzen et al., 2000), did not eliminate CCN1-induced cell
death (Fig. 2 C). Moreover, the addition of 100 ng/ml EGF or 10
ng/ml of basic FGF failed to confer protection from CCN1 cyto-
toxicity (Fig. 2 C). Therefore, CCN1 can actively induce cell
death even in the presence of mitogenic serum growth factors.
The CCN family of proteins includes six homologous
members (Lau and Lam, 1999). Both CCN1 and CCN2 (con-
nective tissue growth factor) are encoded by growth factor–
inducible immediate early genes, induce angiogenesis in vitro
and in vivo, and have similar activities in several cell types (Lau
and Lam, 2005). CCN2 also supports endothelial cell adhesion
through 
 
 
 
v
 
 
 
3
 
, protects the cells from apoptosis, and induces ad-
hesive signaling in fibroblasts similar to CCN1 (Babic et al.,
1999; Chen et al., 2001a). We found that CCN2 also induces
cell death, both as an adhesion substrate in Rat1a fibroblasts
(Fig. 2 D) and when added as a soluble factor (unpublished
data). Thus, both CCN1 and CCN2 are able to promote endo-
thelial cell survival while inducing apoptosis in fibroblasts.
Figure 1. CCN1 induces fibroblast apoptosis
as an adhesion substrate. (A) Rat1a fibro-
blasts were adhered to glass coverslips coated
with 10  g/ml FN, 2.5  g/ml VN, 50  g/ml
CCN1, 10  g/ml LN, or 20  g/ml PLL and
cultured in medium containing 0.5% FBS for
24 h. After fixation, cells were subjected to
TUNEL assay and counterstained with DAPI.
Bar, 10  m. (B) Rat1a cells were adhered to
dishes coated with 20  g/ml PLL, 2  g/ml
FN, 10  g/ml LN, 0.4  g/ml VN, or 10
 g/ml CCN1 and maintained in medium con-
taining 0.5% FBS for 24 h. After fixation and
staining with DAPI, cells were scored for
apoptosis. (C) To test the effect of CCN1 as
an adhesion substrate, HUVECs, HSF, or
Rat1a cells were adhered to culture wells
coated with 10  g/ml CCN1 or 10  g/ml
LN as indicated and maintained for 24 h be-
fore being scored for apoptosis. To test the ef-
fect of CCN1 as a soluble factor, cells were
adhered to tissue culture dishes overnight,
washed, and incubated in serum-free medium
with or without added soluble 10  g/ml
CCN1 for 24 h before being scored for apop-
tosis. (D) Rat1a cells were adhered on dishes
coated with various ECM proteins as indi-
cated and incubated further for 24 h with or
without added 10  g/ml CCN1 before being
scored for apoptosis. (E) Rat1a cells were ad-
hered to dishes coated with 10  g/ml CCN1,
2  g/ml FN, or 20  g/ml PLL for 20 min. Cell
lysates were prepared and resolved on 7.5%
SDS-PAGE, followed by immunoblotting with
antibodies against FAK, phospho-FAK Y397,
or phospho-FAK Y576/577. (F) Rat1a cells
were plated on coverslips coated with FN or
CCN1 as in A and stained with antibodies against phospho-FAK Y397, phospho-paxillin Y118, or control IgG 20 min after plating. Arrowheads point to
staining in focal complexes. Cells were counterstained with DAPI. Bar, 10  m. (G) Cells were adhered to glass coverslips coated with FN or CCN1 as in A,
and stained with antibodies against phospho-JNK T183/Y185 or control IgG 10 min after plating. Cells were counter stained with DAPI. Arrowheads
point to phosphorylated JNK in focal complexes. Bar, 10  m. Error bars represent   SD from experiments done in triplicate. 
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Apoptotic activity of CCN1 is mediated 
through integrin 
 
 
 
6
 
 
 
1
 
 and syndecan-4
 
Because CCN1 induces apoptosis as an adhesion substrate,
we investigated the role of its adhesion receptors, integrin
 
 
 
6
 
 
 
1
 
 and HSPGs (Chen et al., 2000), although neither has
been previously implicated in apoptosis. The presence of sol-
uble heparin in the culture medium blocked CCN1-induced
apoptosis completely (Fig. 3 A), suggesting that soluble hep-
arin may saturate the heparin binding sites of CCN1 and pre-
vent it from interacting with cell surface HSPGs. Consistent
with this interpretation, treatment of fibroblasts with NaClO
 
3
 
,
which inhibits 3-phosphoadenosine 5
 
 
 
-phosphosulfate syn-
thesis and blocks sulfation of proteoglycans, abrogated
CCN1-induced apoptosis (Fig. 3 A). The inhibitory effect of
NaClO
 
3
 
 was reversed by the inclusion in the culture medium
of 10 mM Na
 
2
 
SO
 
4
 
, which overrides the sulfation block ex-
erted by NaClO
 
3
 
 (Rapraeger et al., 1991), thus confirming
that the inhibitory effect of NaClO
 
3
 
 was attributable to im-
paired sulfation of HSPGs. Among the HSPGs expressed in
fibroblasts, syndecan-4 is uniquely colocalized with integrins
in focal adhesions, where it activates PKC in support of cell
adhesion and spreading (Couchman et al., 2001; Simons and
Horowitz, 2001). We found that syndecan-4, but not other
syndecans, is localized to focal adhesion complexes in fibro-
blasts adhered to CCN1 (unpublished data), suggesting that it
might act as an HSPG coreceptor with 
 
 
 
6
 
 
 
1
 
. Preincubation of
fibroblasts with anti–syndecan-4 antibodies completely abol-
ished CCN1-induced apoptosis, whereas control IgG had no
effect (Fig. 3 B). These results support the involvement of a
cell surface HSPG, and implicate syndecan-4 as a coreceptor
that plays a critical role in CCN1-induced apoptosis.
To test the possibility that integrin 
 
 
 
6
 
 
 
1
 
 may also be in-
volved in CCN1-induced apoptosis, we took advantage of
two recently described CCN1 peptides, T1 and H2, which
contain 
 
 
 
6
 
 
 
1
 
-binding sites and are able to block 
 
 
 
6
 
 
 
1
 
-mediated
CCN1 functions (Leu et al., 2003, 2004). Whereas the addi-
tion of synthetic T1 or H2 peptide alone to the culture me-
dium had no effect on cell survival, either peptide was able to
abrogate CCN1-induced apoptosis (Fig. 3 C). The control
peptides T1-mut, a mutated T1 peptide with a two-residue
substitution that rendered it unable to bind 
 
 
 
6
 
 
 
1
 
 (Leu et al.,
2003), and T4, a CCN1 peptide with irrelevant sequence, had
no effect. These results indicate that CCN1-induced apoptosis
requires its binding to 
 
 
 
6
 
 
 
1
 
, for which the T1 and H2 peptides
act as competitive inhibitors. Furthermore, pretreatment of
cells with an anti–
 
 
 
6
 
 integrin monoclonal antibody (GoH3)
completely annihilated the apoptotic activity of CCN1, whereas
control IgG had no effect (Fig. 3 D). These results show that
 
 
 
6
 
 
 
1
 
, in addition to syndecan-4, is required for mediating
CCN1-induced apoptosis.
Figure 2. Apoptotic activities of CCN proteins in Rat1a fibroblasts. (A)
Cells were grown in 6-well plates and treated with the indicated concen-
trations of soluble CCN1 for 24 h, followed by fixation and scoring for
apoptosis. (B) Cells were pretreated for 1 h with 25  M cycloheximide
and 40  M DRB before further incubation for 6 h with or without 10  g/ml
CCN1. Cells were fixed and scored for apoptosis. (C) Cells were grown
in tissue culture dishes in 10% serum, washed, and maintained in me-
dium with 0% FBS, 2% FBS, 100 ng/ml EGF, or 10 ng/ml of basic FGF,
in the presence or absence of 10 mg/ml CCN1 for 24 h before scoring
for apoptosis. (D) Cells were adhered to tissue culture dishes or dishes
coated with CCN1, CCN2, or PLL (10 mg/ml each) and maintained in
medium containing 0.5% FBS with or without soluble CCN1 or CCN2 for
24 h before apoptosis assay. Error bars represent   SD from experiments
done in triplicate.
Figure 3. CCN1 induces apoptosis through integrin  6 1 and HSPGs. (A)
Cells were pretreated with 1 mg/ml heparin for 1 h in serum-free medium
or with 20 mM Na2SO4 and/or 100 mM NaClO3 for 24 h in media con-
taining 10% FBS, after which cells were washed and subjected to further
incubation with or without 10  g/ml CCN1 in serum-free medium contain-
ing the pretreatment level of Na2SO4 and/or NaClO3. (B) Cells were pre-
treated with 100  g/ml of control rabbit IgG or 100  g/ml anti–synde-
can-4 antibody for 1 h in serum-free medium before incubation with or
without CCN1. (C) Cells were pretreated with the peptides T1 (4 mM),
T1-mut (4 mM), H2 (5 mM), or T4 (5 mM) for 1 h before further incubation
with or without 10 mg/ml CCN1. (D) Cells were pretreated with 40  g/ml
GoH3, an mAb against integrin  6, or 40  g/ml of control mouse IgG for
1 h before incubation with or without CCN1. (E) Cells were pretreated for
1 h with GRGDSP and GRGESP peptides (0.2 mM) before further incuba-
tion with or without CCN1. Error bars represent   SD from experiments
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Aside from interaction with the  6 1-HSPG coreceptors,
CCN1 induces fibroblast migration and enhances DNA synthe-
sis through  v 5 and  v 3, respectively (Grzeszkiewicz et al.,
2001). To test the role of  v integrins, cells were treated with a
peptide containing the canonical  v integrin–binding sequence
RGD, which did not protect Rat1a cells from CCN1-induced
apoptosis (Fig. 3 E). The GRGDSP peptide induced apoptosis
on its own, whereas the control peptide GRGESP had no effect.
This apoptotic effect is expected because RGD-containing pep-
tides can activate caspase-3 directly (Buckley et al., 1999).
However, the apoptotic activities of GRGDSP peptide and
CCN1 were additive, indicating that they work through largely
nonoverlapping pathways (Fig. 3 E).
The aforementioned findings indicate the requirement for
 6 1-HSPGs, but not  v-containing integrins, in CCN1-induced
apoptosis. To further substantiate these findings, we evaluated
the importance of direct interaction between CCN1 and these
receptors using CCN1 mutants that are defective in binding
 v 3 or  6 1-HSPGs specifically. Biochemical and functional
studies identified three sites involved in binding  6 1 and
HSPGs in CCN1, namely T1, H1, and H2 (Leu et al., 2003,
2004), whereas the mutation D125A disrupts an  v integrin
binding site, V2 (Chen et al., 2004; Leu et al., 2004). The full-
length CCN1 mutant SM, which disrupts T1 alone, had rela-
tively minor effects, whereas the mutant DM, which alters both
H1 and H2, severely damaged  6 1-HSPG–mediated CCN1
activities. Disruption of all three sites in the mutant TM com-
pletely abolished  6 1-HSPG–mediated functions (Leu et al.,
2004). Consistent with these findings, the mutants DM and TM
were completely defective for induction of apoptosis, whereas
SM showed only modest impairment of apoptotic activity (Fig.
4 A). Notably, all three mutants have intact  v 3 binding sites
and are fully active in  v 3-mediated functions (Leu et al.,
2004), indicating that interaction with  v 3 alone does not in-
duce apoptosis. Furthermore, the mutant D125A, which disrupts
binding to  v 3 and impairs  v 3-dependent CCN1 activities
(Chen et al., 2004), was able to induce apoptosis similar to wild
type (Fig. 4 A). Thus, binding to  v 3 is not critical to the induc-
tion of Rat1a cell apoptosis by CCN1. To determine the receptor
requirement for CCN1-induced apoptosis in HSFs, we exam-
ined the inhibitory effects of monoclonal antibodies that are
available against the human integrins. Monoclonal antibodies
against integrins  6 (GoH3) and  1 (P5D2) strongly inhibited
CCN1-induced apoptosis, whereas antibodies against integrin
 5 (P1D6) or  v 3 (LM609) had no effect (Fig. 4 B). Thus,
CCN1-induced apoptosis is also dependent on integrin  6 1,
but not  v 3, in HSFs.
CCN1 induces apoptosis through the 
intrinsic mitochondrial pathway
The induction of cell death through the ligation of an ECM mol-
ecule to  6 1-HSPGs establishes a novel signaling pathway for
apoptosis. To define the intracellular events involved, we first
analyzed the role of caspases. Two principal apoptotic pathways
involving caspases have been characterized: the extrinsic path-
way, which is induced by direct ligand–receptor interaction,
resulting in the recruitment and activation of caspase-8; and
the intrinsic pathway, which is induced by various stress stimuli
that activate proapoptotic molecules targeting the mitochondria,
rendering the release of cytochrome c and activation of caspase-9
and -3 (Li et al., 1997). Cell-permeable, irreversible inhibitors of
caspase-9 (z-LEHD-fmk) and -3 (z-DEVD-fmk), and of all cas-
pases (z-VAD-fmk), effectively abrogated CCN1-induced apop-
tosis (Fig. 5 A). By contrast, caspase-8 inhibitor (z-IETD-fmk)
had no effect, whereas the same concentration of this inhibitor
completely blocked FasL-induced apoptosis in HSFs (unpub-
lished data). Immunoblot analysis showed that both caspase-9
and -3 were cleaved into their active forms upon CCN1 treat-
ment (Fig. 5 B). These results suggest that CCN1 induces
apoptosis via the intrinsic pathway, in which disruption of mi-
tochondrial integrity leads to cytochrome c release from the
mitochondria to form a complex with Apaf and procaspase-9 to
assemble the apoptosome (Nicholson and Thornberry, 2003).
This process activates caspase-9, which in turn cleaves and
activates caspase-3. To test this possibility, the subcellular
localization of cytochrome c was detected by indirect immu-
nofluorescence labeling using anti–cytochrome c antibodies.
Whereas cytochrome c staining largely followed the mitochon-
dria, the staining became diffuse in CCN1-treated apoptotic
cells, indicating cytochrome c release (Fig. 5 C).
The balance of pro- and antiapoptotic Bcl family members
regulates mitochondrial integrity and activation of the apoptotic
cascade (Cory and Adams, 2002). Transfection of Rat1a cells
with expression vectors for Bcl-2 or Bcl-XL abrogated CCN1-
induced apoptosis, whereas transfection of the empty vector had
no effect (Fig. 5 D). These results suggest the regulation of
Figure 4. Induction of fibroblast apoptosis by CCN1–integrin interaction.
(A) Effects of integrin-binding defective CCN1 mutants in apoptosis in
Rat1a fibroblasts. Cells adhered to 6-well tissue culture plates were either
left untreated or treated with 10  g/ml of soluble wild-type CCN1; 10
 g/ml of the mutants SM, DM, or TM; or 10  g/ml D125A for 24 h, and
apoptosis was assayed. (B) Integrin requirements of CCN1-induced apop-
tosis in HSF. Cells adhered to 6-well plates were either left untreated or
pretreated with 50  g/ml of antibodies against integrin  6 (GoH3),  1
(P5D2),  5 (P1D6),  v 3 (LM609), or control IgG for 1 h. 10  g/ml of sol-
uble CCN1 was added where indicated and apoptosis was assayed 24 h
thereafter. Error bars represent   SD from experiments done in triplicate.JCB • VOLUME 171 • NUMBER 3 • 2005 564
CCN1-induced apoptosis by proapoptotic Bcl family members,
among which the Bax/Bak subfamily plays prominent roles.
Upon activation, both proteins can homooligomerize and local-
ize to the outer mitochondrial membrane to facilitate cytochrome
c release (Cory and Adams, 2002). Because Bax can act down-
stream of integrins (Gilmore et al., 2000), we examined Bax acti-
vation using antibodies specific for the oligomer form of Bax.
Consistent with its involvement in CCN1-induced apoptosis, we
found that Bax oligomerized and colocalized with the mitochon-
dria in apoptotic cells (Fig. 5 C). Furthermore, Bax/Bak double-
null mouse embryonic fibroblasts (MEFs; Wei et al., 2001), but
not the corresponding wild-type MEFs, were resistant to CCN1-
induced apoptosis (Fig. 5 E). Together, these results show that
Bax is activated upon CCN1 treatment and Bax/Bak are indis-
pensable for CCN1-induced apoptosis in fibroblasts.
CCN1-induced apoptosis requires 
p53-dependent Bax activation
p53 is known to induce apoptosis via Bax and Bak, either
through up-regulation of their expression or through protein–
protein interaction to trigger their oligomerization and mito-
chondrial localization (Haupt et al., 2003). To investigate the
potential role of p53 in CCN1-induced apoptosis, we tested the
effects of the genetic suppressor element GSE56, which has
been widely used to inhibit p53 function (Ossovskaya et al.,
1996). Expression of GSE56 completely abolished activation
of Bax upon CCN1 treatment (Fig. 6 A). Furthermore, either
expression of GSE56 or treatment of cells with the p53 inhib-
itor cyclic pifithrin (Pietrancosta et al., 2005) completely
abolished CCN1-induced apoptosis in Rat1a cells (Fig. 6 B).
Likewise, cyclic pifithrin also blocked CCN1-induced apopto-
sis in HSFs (Fig. 6 C). Thus, CCN1-induced apoptosis requires
p53 function, which mediates the activation of Bax.
To establish the role of p53 further, we tested the respon-
siveness of p53-deficient cells. p53-null 10.1 mouse fibroblasts
(Livingstone et al., 1992) were left untreated or were infected
with retroviruses driving the expression of a temperature-sensi-
tive p53 (ts-p53; Wagner et al., 1994) or of the temperature-
sensitive,  transcription transactivation–defective mutant ts-p53
22–23 (Lin et al., 1994). Stable cell populations were selected and
propagated at the nonpermissive temperature (39 C) because pro-
longed exposure to the permissive temperature (33 C) for p53
leads to p21 induction and cell cycle arrest (Buschmann et al.,
2001). After propagation, cells were shifted to 33 C and subjected
to CCN1 treatment in low serum medium. The parental p53-null
10.1 cell line was completely nonresponsive to CCN1-induced
apoptosis, whereas 10.1 cells expressing ts-p53 or ts-p53 22–23
were highly sensitive to CCN1 exposure, showing 20–25% cell
death (Fig. 6 D). These results clearly show that CCN1-induced
apoptosis requires p53 but not its transcription transactivation
activity, which is consistent with this apoptotic process being
independent of de novo transcription and translation (Fig. 2 B).
Figure 5. CCN1 activates the intrinsic apoptotic pathway.
(A) Rat1a cells were pretreated for 1 h with 50  M Z-VAD
(pan-caspase), Z-DEVD (caspase-3), Z-IETD (caspase-8),
and Z-LEHD (caspase-9) inhibitors. Cells were treated
with 10  g/ml CCN1 for 6 h, fixed, and scored for
apoptosis. (B) Cells cultured as in A were treated with
CCN1 for 6 h and lysed in Laemmli buffer. Proteins were
resolved on 12% SDS-PAGE, followed by immunoblotting
with antibodies against caspase-3, caspase-9, or  -actin.
(C) Rat1a cells were adhered on glass coverslips over-
night, washed, and maintained in serum-free medium.
Cells were treated with 10  g/ml CCN1 for 6 h, stained
with MitoTracker for 5 min, fixed, immunostained for ei-
ther Bax or cytochrome c, and counterstained with DAPI.
Arrows point to apoptotic cells. Bar, 10  m. (D) Fibro-
blasts transfected with pBabePuro empty vector or the
same vector driving the expression of Bcl-2 or Bcl-XL were
incubated with or without 10  g/ml CCN1 for 24 h,
fixed, and scored for apoptosis. (E) Immortalized wild-
type or Bax/Bak-null MEFs were incubated with or with-
out 10  g/ml CCN1 for 6 h, fixed, and scored for
apoptosis. Error bars represent   SD from experiments
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Discussion
Numerous studies have demonstrated that integrin-mediated in-
teraction with the ECM can induce prosurvival signals, whereas
detachment from matrix proteins results in rapid apoptotic death
in many cell types (Frisch and Screaton, 2001; Grossmann,
2002). As cell adhesion substrates, specific ECM proteins are
known to promote, or are indifferent to, cell survival with cell
type specificity, and none has been shown to induce apoptosis to
date (Ilic et al., 1998). In this study we show that, unexpectedly,
cell adhesion to the matrix protein CCN1 induces apoptosis in fi-
broblasts but promotes survival in activated endothelial cells.
Thus, a new category of cell adhesion events that induce apopto-
sis is beginning to emerge, suggesting that cellular interaction
with the ECM can help to program both cell survival and death in
a cell type–specific manner. Furthermore, CCN1-induced apop-
tosis in fibroblasts is p53 dependent and is mediated through its
cell adhesion receptors,  6 1 and the HSPG syndecan-4, thus
linking these receptors to apoptotic pathways for the first time.
Most of the activities of CCN proteins identified to date
in isolated cell systems can be attributed to their direct interac-
tion with integrin receptors, which function with HSPGs as
coreceptors in some contexts (Lau and Lam, 2005). It is well
documented that CCN1 supports fibroblast adhesion through
integrin  6 1 and HSPGs, and the CCN1 binding sites for
these receptors have been identified (Leu et al., 2003, 2004).
Remarkably, these adhesion receptors also mediate CCN1-
induced fibroblast apoptosis (Figs. 3 and 4). Analyses of
CCN1 mutants indicate that the CCN1 binding sites H1 and
H2, which interact with both  6 1 and HSPGs, are essential for
apoptotic activity. By contrast, the T1 site, which binds  6 1,
or the V2 site, which binds integrin  v 3, is not essential (Fig. 4).
These results suggest that concomitant binding of CCN1 to
both   6 1 and HSPGs, possibly through closely juxtaposed
binding sites, may be necessary for induction of apoptosis.
Such a requirement might explain why other  6 1 ligands, such
as LN, do not induce apoptosis (Fig. 1). Furthermore, our stud-
ies suggest syndecan-4 as the HSPG that acts with  6 1 to in-
duce apoptosis (Fig. 3 B), thus implicating  6 1 and syndecan-4
as apoptotic receptors.
Cell type–specific differences have been observed regard-
ing the regulation of apoptosis by cell adhesion events. Epithelial
and endothelial cells undergo rapid cell death by anoikis when
detached from the ECM, whereas fibroblasts are resistant to such
a challenge for a prolonged period of time (Meredith et al.,
1993). The differential effects of CCN1 on endothelial cells as
opposed to fibroblastic cells can be ascribed to distinct integrin
utilization in these cell types. CCN1 confers proangiogenic and
antiapoptotic functions in activated endothelial cells through li-
gation to integrin  v 3, whose ability to transduce cell survival
signals is well documented (Eliceiri and Cheresh, 2000; Leu et
al., 2002). Furthermore, vascular cells in Ccn1-null mice suffer a
high level of apoptosis, showing that CCN1 is critical for sus-
taining vascular cell survival in vivo (Mo et al., 2002). By con-
trast, CCN1 induces apoptosis in fibroblasts through its adhesion
receptors,  6 1 and syndecan-4, thereby selectively promoting or
suppressing apoptosis in different cell types through the engage-
ment of distinct integrins.
Fibroblast adhesion to CCN1 induces adhesive signaling
including the activation of FAK (Fig. 1 E), which is generally
associated with a prosurvival outcome (Frisch and Screaton,
2001). Although ECM molecules such as FN are highly effi-
cient in promoting the survival of fibroblasts through activation
of FAK (Ilic et al., 1998), cells adhered to FN or to their endog-
enous matrices are nevertheless susceptible to CCN1-induced
apoptosis (Fig. 1). The presence of 2% serum or mitogenic
growth factors (Fig. 2 C) also did not prevent CCN1-induced
apoptosis. Thus, CCN1 can induce cell death despite the pro-
survival signals conferred by either matrix molecules or growth
factors and must activate signaling pathways that override cell
adhesion–dependent prosurvival signals. These findings sug-
gest that CCN1 can induce apoptosis under physiological con-
ditions, such as during wound healing (Chen et al., 2001b),
where cells may be attached to prosurvival ECM proteins and
exposed to growth factors and cytokines.
The loss of proper integrin–ligand interactions can lead to
apoptosis. Anoikis, or apoptosis resulting from detachment
from the ECM, has been associated with activation of caspase-8
or p53 (Frisch and Screaton, 2001; Grossmann, 2002), although
a caspase-independent mechanism of anoikis also occurs (Jan et
al., 2004). In adherent cells, unligated integrins can also recruit
Figure 6. CCN1 induces p53-dependent Bax activation. (A) Rat1a cells
were transfected with either the pBabePuro vector or the same vector ex-
pressing GSE56. Cells were incubated with or without 10  g/ml CCN1
for 6 h and immunostained and scored for activated Bax. (B) Cells were
transfected with either the pBabePuro vector or the same vector expressing
GSE56, or were pretreated with 200  M of cyclic pifithrin for 1 h. Cells
were incubated with or without 10  g/ml CCN1 for 24 h and scored for
apoptosis. (C) Primary human fibroblasts were either untreated or pre-
treated with 200 mM of cyclic pifithrin for 1 h and incubated with or with-
out 10 mg/ml CCN1 for 24 h, as indicated, before scoring for apoptosis.
(D) Parental 10.1 cells and cells transfected with pMV7 containing either
temperature-sensitive p53 (ts-p53)or transcription transactivation inactive
temperature-sensitive p53 (ts-p53 22–23) were transferred from nonper-
missive (39 C) to permissive temperature (33 C) for 24 h to regain func-
tional p53 protein. Cells were incubated with medium containing 0.5%
FBS and treated with 10 mg/ml CCN1 for the next 6 h. Cells were fixed
and scored for apoptosis. Error bars represent   SD from experiments
done in triplicate.JCB • VOLUME 171 • NUMBER 3 • 2005 566
and activate caspase-8, leading to “integrin-mediated death”
(Stupack et al., 2001). CCN1-induced apoptosis is independent
of caspase-8 and is instead mediated through the mitochondrial
pathway (Fig. 5). In this context, p53 is required for the acti-
vation of Bax, which in turn leads to cytochrome c release
and activation of caspase-9 and -3 (Figs. 5 and 6). p53 is known
to mediate apoptosis through both transcription-dependent
and -independent mechanisms (Haupt et al., 2003; Slee et al.,
2004). As a transcription factor, p53 activates proapoptotic
genes encoding Bax, the BH3-only proteins PUMA and Noxa,
AIP-1, Apaf-1, and PERP. It can also repress antiapoptotic
genes encoding Bcl2 and immunosuppressive acidic proteins.
Because preincubation of cells with cycloheximide and DRB
did not block CCN1-induced apoptosis (Fig. 2 B), and transac-
tivation-defective p53 was able to restore CCN1-induced apop-
tosis in p53-null cells, we conclude that p53 acts through a
transcription-independent mechanism in this context. Our results
showing the transcription-independent, p53-mediated activation
of Bax in CCN1-mediated apoptosis (Fig. 6) are consistent with
recent findings that direct interaction of p53 with Bax/Bak, or
with Bcl family members to displace BH3-only proteins, can
lead to Bax activation and apoptosis independent of de novo pro-
tein synthesis (Mihara et al., 2003; Chipuk et al., 2004).
Both CCN1 and its homologous family member CCN2
are angiogenic in vitro and in vivo, support cell adhesion and
promote survival in endothelial cells, and induce adhesion sig-
naling in HSFs in a similar manner (Chen et al., 2001a; Lau
and Lam, 2005). Like CCN1, CCN2 also induces fibroblast
apoptosis, suggesting that the control of cell survival and death
may be a general function of CCN proteins (Fig. 2 D). The
finding that CCN1 and CCN2 are novel proapoptotic matrix
molecules has implications on their biological roles in vivo.
CCN1 and CCN2 are both encoded by growth factor–inducible
immediate early genes, and their expression in the adult is asso-
ciated with biological and pathological events that involve
apoptosis, such as in wound healing, arthritis, and tumorigene-
sis (Lau and Lam, 1999; for review see Menendez et al., 2003;
Planque and Perbal, 2003). It is tempting to speculate that their
dynamic expression in the ECM may regulate cell survival and
death during tissue remodeling, including the resolution of
granulation tissue during wound healing.
Integrin-mediated signaling resulting from engagement of
ECM proteins is known to regulate diverse biological processes,
and its role in promoting cell survival is well established (Pullan
et al., 1996; Colognato et al., 2002). It has been observed that in
human mammary epithelial cells where p53 function was sup-
pressed, exposure to reconstituted ECM can induce growth arrest
followed by apoptosis in an integrin  3/ 1-dependent fashion
(Seewaldt et al., 2001). These observations suggest that p53 may
suppress, rather than mediate, apoptotic signals from the ECM.
Nevertheless, these results reinforce our findings that matrix pro-
teins can transduce apoptotic signals via integrins and suggest
that the induction of apoptosis by the ECM may be more general
than originally thought. Thus, in addition to the two well charac-
terized categories of cell adhesion events—one that promotes
cell survival and one that is neutral to this process—evidence of
another category that induces apoptosis is beginning to emerge.
Materials and methods
Cell culture
Rat1a, 10.1 p53-null fibroblasts (Livingstone et al., 1992), and MEFs from
either wild-type or Bax/Bak double-null animals (Wei et al., 2001) were
grown at 37 C with 10% CO2 in DME (Invitrogen) containing 10% FBS
(Intergen). Normal HSFs were obtained from the American Type Culture
Collection (CRL-2076) and maintained in Iscove’s modified DME (Invitro-
gen) with 10% FBS at 37 C with 5% CO2 and used before passage 8.
Primary HUVECs were maintained at 37 C with 5% CO2 in Medium 200
containing 2% serum and endothelial growth supplements (Cascade Biolog-
ics, Inc.). Cells were used between passages 16–20 to ensure activation of
integrin  V 3 (Leu et al., 2002). Rat1a cells stably expressing Bcl-2 and Bcl-
XL were prepared by infection with retroviruses that drive their expression
(Gottlob et al., 2001), and cells harboring the empty vector (pBabePuro)
were used as controls. The 10.1 p53-null fibroblasts were stably transfected
with a pMV7-derived vector driving expression of a temperature-sensitive
p53 (Wagner et al., 1994) or a temperature-sensitive, transcription transac-
tivation–defective p53 mutant (Lin et al., 1994), and grown at 39 C.
Growth at 33 C is permissive for expression of p53 activity in these cells.
Proteins, antibodies, peptides, and reagents
Wild-type and mutant CCN1 were produced using the baculovirus expres-
sion system and purified as previously described (Chen et al., 2004; Leu
et al., 2004). Human FN and mouse LN were purchased from BD Bio-
sciences. Recombinant human EGF and basic FGF were obtained from In-
vitrogen. DRB, human VN, monoclonal anti– -actin antibody (AC-15),
and rabbit and mouse IgGs were purchased from Sigma-Aldrich. Function-
blocking mAbs against integrins, including NKI-GoH3 (anti- 6), P5D2
(anti- 1), P1D6 (anti- 5), and LM609 (anti- V 3) were purchased from
CHEMICON International, Inc. Function-blocking antibodies against syn-
decan-4 and TRITC-conjugated mAb against phospho-JNK T183/Y185
were obtained from Santa Cruz Biotechnology, Inc. Monoclonal anti–cyto-
chrome c (6H2.B4) and anti-Bax (6A7) antibody were obtained from BD
Biosciences. Rabbit polyclonal caspase-3, -9, FAK, phospho-FAK Y576/
577, and phospho-paxillin Y118 antibodies were purchased from Cell
Signaling Technology, and antibodies against phospho-FAK Y397 were
obtained from Calbiochem. HRP-conjugated anti–mouse and anti–rabbit
secondary antibodies were purchased from GE Healthcare. Alexa Fluor
488–conjugated anti–mouse and anti–rabbit secondary antibodies were
obtained from Invitrogen. Synthetic GRGDSP and GRGESP peptides were
purchased from Life Technologies, Inc. The synthetic peptides T1 (GQK-
CIVQTTSWSQCSKS), T1-mut (GQKCIVQTTSAAQCSKS), T4 (RLVKET-
RICEVRPCGQPVYSSLK), and H2 (FTYAGCSSVKKYRPKY) were prepared
by Research Genetics (Leu et al., 2003, 2004). The pan-caspase inhibitor
Q-VD-Oph was purchased from Valeant Pharmaceuticals; the pan-caspase
inhibitor z-VAD-fmk, caspase-3 inhibitor z-DEVD-fmk, caspase-8 inhibitor
z-IETD-fmk, caspase-9 inhibitor z-LEHD-fmk, cyclic pifithrin- , and cyclo-
heximide were purchased from Calbiochem. The mitochondrion-selective
probe MitoTracker Orange was obtained from Invitrogen.
Apoptosis assays
To examine cell death resulting from cell adhesion, cells were plated in me-
dium supplemented with 0.5% FBS on 35-mm Petri dishes precoated over-
night with various proteins. After 24 h of incubation, cells were fixed with a
10% formaldehyde solution overnight, washed with PBS, and stained by
1  g/ml DAPI in 1  PBS. Apoptotic cells were quantified by DAPI staining
as described previously (Kennedy et al., 1997). A total of five random fields
were counted per sample, with a minimum of 50 cells per field. All exper-
iments were repeated at least twice in triplicate. In experiments where ap-
optotic factors were added in a soluble form, cells were plated at a low
density (50,000 cells per well in a 6-well plate) overnight, replaced with
serum-free medium (unless otherwise indicated), and treated with test mole-
cules for 24 h. In experiments using inhibitors with cytotoxicity (e.g., cyclo-
heximide, DRB, and caspase inhibitors), cells were plated at high density
(500,000 cells per well in a 6-well plate) and assayed 6 h after treatment.
For the TUNEL assay, fibroblasts were plated on glass coverslips coated
with test proteins and cultured in basal medium containing 0.5% FBS for
24 h. Apoptosis was assayed using the ApopTag Red in situ Apoptosis De-
tection Kit as instructed by the manufacturer (CHEMICON International,
Inc.), and cells were counterstained with DAPI. Cells were then observed us-
ing standard UV, rhodamine, or FITC filters by fluorescence microscopy
using an inverted microscope (model DM IRB/E; Leica). Images were ob-
tained with a digital camera (model DC-330; Dage-MTI, Inc.) and Image-
Pro Plus software (Media Cybernetics, Inc.). All image processing in this pa-
per was performed using Canvas 7 (ACD Systems, Inc.).CCN1 INDUCES FIBROBLAST APOPTOSIS • TODOROVI  ET AL. C ´ 567
Immunoblot analysis
To detect FAK activation, Rat1a cells were serum-starved overnight, de-
tached with trypsin-free cell detachment solution (2.5 mM EDTA and 0.1%
wt/vol glucose in 1  PBS), and plated in serum-free medium on 35-mm
dishes coated with test proteins. For immunoblotting, equal amounts of
proteins from cell lysates were separated on 12% (caspases) or 7.5%
(FAK) SDS-PAGE and transferred to a nitrocellulose membrane. The mem-
brane was blotted with primary antibodies, detected by secondary anti-
bodies, and developed by chemiluminescence (GE Healthcare).
Indirect immunofluorescence
To localize cytochrome c and Bax, Rat1a cells were adhered on glass cov-
erslips overnight and treated with serum-free medium with or without
CCN1 for 6 h. To label the mitochondria, 100 nM of MitoTracker was
added for 5 min before fixation with 3% PFA. Cytochrome c immunostain-
ing was performed as described previously, with minor modifications
(Kennedy et al., 1997). In brief, cells were permeabilized by incubation in
0.2% saponin, blocked with 10% normal goat serum, and stained with
1  g/ml of monoclonal anti–cytochrome c antibody and 1  g/ml of Al-
exa Fluor 488–conjugated secondary antibody. For Bax localization,
PFA-fixed cells were permeabilized with 1% Triton X-100, blocked with
1% BSA, and stained with polyclonal anti-Bax antibodies. Cells were ob-
served by fluorescence microscopy using an Optiphot microscope (Nikon).
Photographs were taken with a 35-mm camera (model FX-35WA; Nikon)
and scanned with a Perfection scanner (Epson) using TWAIN 5 software
(Epson) to import images to Canvas.
To quantify Bax activation, Rat1a cells were adhered on 2-well per-
manox slides (Nalge Nunc), pretreated with 100  M of pan-caspase in-
hibitor, and treated with test molecules as described in Apoptosis assays.
Cells were fixed and stained with 0.5  g/ml mAb against Bax and 1  g/ml
of TRITC-conjugated anti–mouse antibody (Jackson ImmunoResearch Labo-
ratories). Cells were rinsed and coverslips were mounted onto slides using
the aqueous mounting solution Crystal/Mount (Biomeda). To stain for FAK
or paxillin, cells were plated on glass coverslips coated with either 10
 g/ml FN or 50  g/ml CCN1 for 20 min, fixed, and permeabilized as
for Bax immunostaining before staining with the cognate antibodies and
1  g/ml of Alexa Fluor 488–conjugated secondary antibody. Cells were
observed by fluorescence microscopy using a microscope (Axioplan 2;
Carl Zeiss MicroImaging, Inc.). Images were obtained with a digital cam-
era (Axiocam HR) and Axiovision software (Carl Zeiss MicroImaging,
Inc.). To stain for phosphorylated JNK, cells were plated for 10 min on FN-
or CCN1-coated coverslips as for Bax immunostaining, stained with 4
 g/ml of TRITC-conjugated antibody against phospho-JNK T183/Y185 or
4  g/ml of TRITC-conjugated mouse IgG (Jackson ImmunoResearch Labo-
ratories), and counter stained with DAPI.
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